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Abstract 
Among the 20 directly-encoded proteinogenic amino acids, arginine is one of five remaining 
cases for which the crystal structure of a racemic crystalline phase has not yet been reported. In this 
paper, the crystal structure of DL-arginine is determined by exploiting modern methods for analysis 
of powder X-ray diffraction data, in conjunction with periodic DFT-D calculations. The crystal 
structure of DL-arginine provides interesting contrasts and comparisons to that of the 
enantiomerically pure crystalline phase (L-arginine), which was also determined recently from 
powder X-ray diffraction data. 
Introduction 
While there is significant interest in the solid-state properties of the 20 directly-encoded 
proteinogenic amino acids, it is only very recently that the crystal structures of the enantiomerically 
pure forms have been reported for all members of this family.1 Following the first crystal structure 
determination2 of an amino acid in this family in 1939, it took over 70 years before the crystal 
structures of the enantiomerically pure forms of all 19 chiral amino acids in this family were 
determined, with the reported crystal structure determinations of L-arginine3 and L-tryptophan4 in 
2013, and L-lysine5 in 2015. Furthermore, within the last few years, a completely new 
understanding of the polymorphic landscape for L-phenylalanine has emerged, with the discovery of 
three new polymorphs6-7 and revision of the structure of the only previously known form.7 
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In contrast, there has been significantly less progress in establishing the crystal structures of 
racemate crystalline forms (in which both the R-enantiomer and the S-enantiomer are present in 
equal amounts within the crystal structure). Of the 19 chiral members of the set, racemate crystal 
structures are known in 14 cases, the most recently reported of which were DL-isoleucine8 in 2000 
and a second polymorph of DL-cysteine9 (at low temperature) in 2009. The fact that less progress 
has been made in structural characterization of the racemate crystalline phases may be related to the 
fact that, in crystallization of racemic systems, the formation of a racemate crystalline phase 
competes with the alternative crystallization pathway leading to the formation of a conglomerate 
phase (i.e., a physical mixture of enantiomerically pure crystals of the R-enantiomer and 
enantiomerically pure crystals of the S-enantiomer). At the present time, there are five members of 
the family of amino acids for which no racemate crystal structure has been reported: asparagine, 
phenylalanine, threonine, arginine and lysine. In three of these cases, the formation of 
conglomerates on crystallization from racemic solutions has been reported, specifically for 
asparagine,10 phenylalanine7 and threonine.11 Clearly, however, we cannot rule out the possibility 
that experimental conditions could be found under which DL-asparagine, DL-phenylalanine and 
DL-threonine would crystallize as racemates rather than conglomerates. To our knowledge, there 
have been no reports of the formation of non-solvate crystalline phases on crystallization from 
racemic solutions of DL-arginine and DL-lysine, although crystal structures have been reported for 
both monohydrate12 and dihydrate13 phases of DL-arginine. The present paper is focused on crystal 
structure determination of DL-arginine (non-solvate crystalline phase), which has been achieved by 
exploiting the opportunities provided by modern methods for analysis of powder XRD data, 
combined with periodic DFT-D calculations. 
Although the task of determining crystal structures from powder X-ray diffraction (XRD) data 
is significantly more challenging than from single-crystal XRD data, advances over the past 20 
years or so in techniques for analysis of powder XRD data14-19 (particularly, the development of the 
direct-space strategy for structure solution) are such that the structural properties of organic 
materials of moderate complexity can now be determined from powder XRD data. In this regard, 
we note that there is growing interest5,20-28 in utilizing periodic DFT calculations in conjunction 
with the analysis of powder XRD data, both for validation of the structural model and for enhancing 
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the quality of the structure at different stages of the structure determination process. The capability 
to determine the crystal structures of organic materials directly from powder XRD data has created 
considerable opportunities for structural characterization of materials prepared by processes that 
intrinsically generate microcrystalline powders as the product phase, including those prepared by 
solid-state desolvation (e.g., dehydration) processes.3,5,6,29,30 
The opportunity to carry out structure determination of amino acids directly from powder 
XRD data is particularly advantageous in those cases for which hydrate phases are formed readily 
(for example, by incorporation of water from the atmosphere). In such cases, the anhydrous solid 
form is most readily accessed by solid-state dehydration of a hydrate phase. As such processes have 
a high propensity to produce the anhydrous phase as a microcrystalline powder, the only viable 
opportunity for crystal structure determination is the analysis of powder XRD data. This situation 
arises for both L-arginine and L-lysine, and thus powder XRD was essential for structure 
determination of the anhydrous phases in these cases.3,5 
A similar situation applies in the case of DL-arginine (Figure 1), as both monohydrate12 and 
dihydrate13 solid forms of DL-arginine are known and the anhydrous form readily undergoes 
hydration in contact with atmospheric water. Indeed, one of the challenges in carrying out crystal 
structure determination of the anhydrous form of DL-arginine in the present work was to prevent 
hydration of the material during handling and measurement of the powder XRD data. 
Methods 
DL-Arginine was purchased from Alfa Aesar as a polycrystalline powder, which was kept 
under dry conditions to prevent conversion to a hydrate form through exposure to atmospheric 
water. For powder XRD measurements, the sample was loaded into two glass capillaries which 
were then flame sealed. Powder XRD data were recorded at ambient temperature (21 °C) on a 
Bruker D8 Diffractometer (Ge-monochromated CuKα1 radiation) operating in transmission mode 
with a Våntec detector covering 3° in 2θ. The powder XRD data31 were recorded in the 2θ range 
from 4° to 50° (step size 0.017°). The total data collection time was 16 hours. 
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Unit cell determination was carried out using the program Crysfire,32 which applies a range of 
different indexing algorithms to a set of peak positions measured from the powder XRD pattern. 
Profile fitting (using the Le Bail method33) and Rietveld refinement34 were carried out using the 
program GSAS.35 Structure solution was carried out using the direct-space strategy implemented in 
the program EAGER,36-42 which is based on a genetic algorithm search procedure. 
Periodic DFT-D calculations for geometry optimization were carried out (in conjunction with 
different stages of Rietveld refinement, as discussed below) using the program CASTEP43 
(Academic Release version 8.0). These calculations utilized ultrasoft pseudopotentials,44 the PBE 
functional,45 semiempirical dispersion corrections (TS correction scheme46), fixed unit cell, 
preserved space group symmetry, periodic boundary conditions, a basis set cut-off energy of 700 eV 
and a Monkhorst-Pack grid47 of minimum sample spacing 0.05 × 2π Å−1. 
Structure Determination 
The powder XRD pattern of DL-arginine was indexed using the TREOR90 algorithm,48 giving 
a unit cell with orthorhombic metric symmetry and unit cell axes of the following lengths: 5.37 Å, 
9.20 Å, 18.26 Å. From the volume of the unit cell and consideration of density, the number of 
molecules in the unit cell was deduced to be Z = 4 (i.e., two molecules of L-arginine and two 
molecules of D-arginine). Profile fitting using the Le Bail technique led to an acceptable quality of 
fit for 23 combinations of orthorhombic space groups and different permutations of the unit cell 
axis lengths, and structure solution was attempted in each of these cases. In these structure solution 
calculations (discussed in more detail below), only space group Pna21 (with the following ordering 
of the unit cell axes: a = 18.26 Å, b = 5.37 Å, c = 9.20 Å) yielded trial structures for which: (a) the 
arrangement of the molecules was structurally and chemically reasonable, and (b) a good fit to the 
experimental powder XRD data was achieved. The result from Le Bail fitting of the powder XRD 
data for this unit cell and space group is shown in Figure 2 (2θ range,49 7° to 50°; Rwp = 1.95%, 
Rp = 1.51%). 
Structure solution was carried out using the direct-space strategy implemented using a genetic 
algorithm search technique in the program EAGER. For space group Pna21 with Z = 4, there is one 
molecule in the asymmetric unit (Z' = 1) and, in the direct-space structure solution calculations, 
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each trial structure was defined by a total of 11 structural variables (three positional, three 
orientational and five torsional). The tautomeric form of the molecule shown in Figure 1 was used, 
based on the reported crystal structure of L-arginine.3 In total, 16 independent calculations were 
carried out, in each case for a population of 100 structures, with 40 mating and 30 mutation 
operations carried out per generation, and for a total of 100 generations. The trial structure giving 
the best fit to the experimental powder XRD data in each of the 16 calculations represented 
essentially the same structure and the trial structure with lowest Rwp among all 16 calculations was 
used as the starting structural model for Rietveld refinement.34 In the Rietveld refinement, standard 
restraints50 were applied to bond lengths and bond angles, and planar restraints were applied to the 
carboxylate and guanidinium groups. 
After the initial Rietveld refinement (Rwp = 2.23%, Rp = 1.64%), the structural model was 
subjected to geometry optimization using periodic DFT-D calculations (with fixed unit cell), which 
led to only a minor change in the molecular conformation. The resulting geometry optimized 
structure was then used as the starting structural model for a second stage of Rietveld refinement, 
which produced only very minor structural adjustments and a small improvement in the quality of 
fit. At the final stage of Rietveld refinement, an additional distance restraint was applied across the 
intermolecular N–H···O hydrogen bond involving the amine and carboxylate groups in the amino 
acid head groups of adjacent molecules (the periodic DFT-D calculations indicated that a rather 
long hydrogen bond is formed between these groups, as discussed below). The final Rietveld 
refinement49 is shown in Figure 3 [2θ range, 7 to 50°; 2519 profile points; 95 refined variables; 
Rwp = 2.21%, Rp = 1.65%, Rwpbs = 1.96%, Rpbs = 1.81%, 2 = 1.613 (Rwpbs and Rpbs are the 
background subtracted values of Rwp and Rp, respectively)]. No corrections for preferred orientation 
were applied in the Rietveld refinement and analysis of the difference Fourier map generated from 
the final Rietveld refinement confirmed that there are no significant regions of electron density 
mismatch. The level of agreement between calculated and experimental powder XRD data achieved 
in the Rietveld refinement compares very favourably with that obtained in the Le Bail fitting 
procedure (Figure 2), leading to the conclusion that a Rietveld refinement of acceptable quality had 
been achieved. 
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Results and Discussion 
The final refined crystal structure of DL-arginine is shown in Figures 4 and 5. The structure 
may be described in terms of a three-dimensionally connected array of intermolecular N–H···O 
hydrogen bonds, within which a number of well-defined hydrogen bonding motifs may be 
identified. First, chains of alternating L-arginine and D-arginine molecules propagate along the 
a-axis (horizontal in Figure 4, with one chain highlighted in cyan); within these chains, carboxylate 
and guanidinium groups in neighbouring molecules are linked by a double hydrogen-bonded ring 
designated )8(R22  in graph set notation
51-52 (illustrated by the red circle in Figure 4). These chains 
are not straight but instead exhibit a zig-zag topology within the ab-plane (see Figure 5). Along the 
b-axis, adjacent zig-zag chains of this type are linked by a rather long, but very linear, N–H···O 
hydrogen bond (N···O distance, 3.64 Å; N–H···O angle, 175.9°; see Figure 5) involving the amine 
and carboxylate groups in the amino acid head-groups of molecules in adjacent chains. Along the 
c-axis, adjacent zig-zag chains are linked by further N–H···O hydrogen bonding, involving pairs of 
molecules (an example is highlighted in magenta in Figure 4) of the same chirality linked through 
three N–H···O hydrogen bonds, specifically: (a) at one end of each molecule, there are two N–
H···O hydrogen bonds between the guanidinium group of one molecule and a carboxylate oxygen 
atom of the other molecule, giving rise to a cyclic motif (designated )6(R12  in graph set notation; 
illustrated by the green circle in Figure 4) and (b) at the other end of each molecule, there is a single 
N–H···O hydrogen bond between guanidinium and carboxylate groups. Finally, a helical hydrogen-
bonded chain running along the b-axis may also be identified (designated )8(C24  in graph set 
notation; illustrated by the light blue curved arrow in Figure 4). This helical chain runs along a 21 
screw axis and the repeat unit, which involves four different molecules, is constructed from an 
alternation of guanidinium NH2 groups and carboxylate oxygen atoms as follows: ···H–N–
H···O···H–N–H···O. We note that all the N–H···O hydrogen bonds within this helical )8(C24  chain 
motif are also present in one of the other hydrogen-bonding motifs discussed above. 
Certain aspects of the crystal structure of DL-arginine resemble features in the crystal structure 
of L-arginine,3 which also contains zig-zag chains in which adjacent molecules in the chain are 
linked by the same double hydrogen-bonded )8(R22  ring motif involving guanidinium and 
carboxylate groups of adjacent molecules. The angle formed at the “bend” within the zig-zag chain 
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(defined as the angle between the planes containing the hydrogen-bonded groups) is higher for 
DL-arginine (102°) than L-arginine (76° and 81° for the two crystallographically independent 
chains). However, there are much more significant differences between the crystal structures of 
L-arginine and DL-arginine with regard to details of the hydrogen bonding between adjacent zig-zag 
chains. Significantly, in the crystal structure of L-arginine, the amine group in the amino acid head-
group is engaged in three intermolecular hydrogen bonds (as the donor in two N–H···O hydrogen 
bonds and as the acceptor in one N–H···N hydrogen bond), whereas in the crystal structure of 
DL-arginine, this NH2 group forms just one intermolecular hydrogen bond (as the donor in an N–
H···O hydrogen bond) together with an intramolecular N–H···O hydrogen bond to a carboxylate 
oxygen atom in the same molecule. For comparison, Figure S1 (Supporting Information) shows the 
hydrogen-bonded chains of arginine molecules in the crystal structures of L-arginine and 
DL-arginine, as well as the hydrogen-bonded chains in the crystal structures of L-arginine dihydrate, 
DL-arginine monohydrate and DL-arginine dihydrate. 
The crystal structures of DL-arginine and L-arginine both have four molecules in the unit cell, 
and as the unit cell volume is larger by 3.6% (at ambient temperature) for DL-arginine than for 
L-arginine, the density of DL-arginine is lower (1.29 g cm–3 for DL-arginine and 1.34 g cm–3 for 
L-arginine). Thus, arginine represents an exception to Wallach’s rule,53-54 which states that racemate 
crystalline phases have higher density than the enantiomerically pure crystalline phases of the same 
molecule. In 2012, Dunitz and Gavezzotti55 showed that, of the 13 proteinogenic amino acids for 
which crystal structures of both the racemic and enantiomerically pure forms were known at that 
time, Wallach’s rule is obeyed in eight cases and not obeyed in five cases. Our observation for 
arginine reported here further reinforces the conclusion that Wallach’s rule does not apply to this 
class of materials. 
Concluding Remarks 
The crystal structure of DL-arginine reported in this paper provides further demonstration of 
the opportunities that now exist for determining the crystal structures of organic molecular materials 
by exploiting modern methods for analysis of powder XRD data. Clearly, this strategy enables 
structural knowledge to be obtained for materials that cannot be prepared as crystals of suitable size 
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and quality for single-crystal XRD. Furthermore, we emphasize the significant advantages of 
utilizing periodic DFT-D calculations at various stages within the structure determination protocol, 
both for validating the structural model derived from powder XRD data and for improving the 
accuracy of the structural model (for example, determining reliable positions of hydrogen atoms). 
We anticipate that the combined powder XRD/DFT-D strategy will also prove to be advantageous 
in structure determination in the remaining four cases of amino acids for which a (non-solvate) 
racemate crystal structure has not yet been reported, provided, of course, that experimental 
procedures can be found that lead to the formation of a racemate crystalline phase rather than a 
conglomerate in these cases. 
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Figures 
 
Figure 1. Molecular structure of arginine in the tautomeric form found in the known crystal 
structure of L-arginine3 and in the crystal structure of DL-arginine reported here. The star indicates 
the stereogenic centre. L-Arginine is designated as the S-enantiomer and D-arginine is designated as 
the R-enantiomer. 
 
 
Figure 2. Le Bail fitting of the powder XRD data (with background subtracted) of DL-arginine (red 
+ marks, experimental data; green line, calculated data; magenta line, difference plot; black tick 
marks, predicted peak positions). 
14 
 
Figure 3. Final Rietveld refinement (with background subtracted) of DL-arginine (red + marks, 
experimental data; green line, calculated data; magenta line, difference plot; black tick marks, 
predicted peak positions). 
 
Figure 4. Crystal structure of DL-arginine viewed along the b-axis. Green dashed lines indicate 
hydrogen-bonding interactions. Chains of alternating D-arginine and L-arginine molecules propagate 
parallel to the a-axis (horizontal in the view shown, with one chain highlighted in cyan). These 
chains actually have a zig-zag topology, as evident when viewed along the c-axis in Figure 5. 
Adjacent molecules (of the same chirality) along the c-axis are also linked by hydrogen-bonding 
interactions (one pair of molecules is highlighted in magenta). Hydrogen-bonding motifs discussed 
in the text are indicated as follows: red circle, )8(R
2
2  ring; green circle, )6(R
1
2  ring; light-blue 
curved arrow, helical chain [ )8(C24 ] running along the b-axis (into the plane of the page). 
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Figure 5. Crystal structure of DL-arginine viewed along the c-axis, showing three zig-zag chains 
propagating along the a-axis (horizontal). Green dashed lines indicate hydrogen-bonding 
interactions. Note that each molecule is engaged in an N–H···O hydrogen bond with a molecule in 
each of the two adjacent chains. 
